HomeOpen Access News

Open Access News

Why the Government urgently must focus on the next AI wave  

Aaron Jones of Yepic AI warns that the UK Government’s outdated focus on legacy issues in artificial intelligence regulation is risky.

Horizon Europe: A new momentum for European Research & Innovation

Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth explains why Horizon Europe, the new EU research and innovation programme, will play a crucial role in empowering EU research and innovation to shape a healthy, green and digital future.

Current Direct: EU project for swappable container waterborne transport batteries

Shaun White, Technical Project Manager of the Current Direct project, tells us what we need to know about how this research & innovation project will revolutionise how we move goods & people by water.

Healthy biodiversity: The key to reaching the blue bioeconomy’s full potential

Nicolas Pade & Sabrina Gaber of the European Marine Resource Centre discuss optimising exploration and exploitation of the blue bioeconomy.

IT Pro Day 2021: Adapting to an evolving landscape

In light of IT Pro Day 2021, industry experts comment on what it means to be an IT professional, the hurdles they face and overcome, and how all businesses can give these employees the recognition they deserve.

WHO guidance: Feasibility of community mental health

Jonas Bull, Policy and Research Officer at Mental Health Europe, sheds light on new WHO guidance that demonstrates the feasibility of community mental health services based on human rights.

Computational methods for modelling 3D structures of protein complexes

Here, we learn about Daisuke Kihara, Professor of Biological Sciences and Computer Science at Purdue University, who develops state-of-the-art computational methods for modelling 3D structures of protein complexes.

Neurological disorders: Developing therapies for cats, dogs & patients

Charles H. Vite, DVM, PhD from School of Veterinary Medicine at University of Pennsylvania, focuses on a fascinating aspect of neurological disorders concerning developing therapies for cats, dogs & patients.

A look at Carbon Zero Cities

Peder Vejsig Pedersen from European Green Cities provides a fascinating glimpse at Carbon Zero Cities.

The effect of cloud on modern backup

Jeremy Wyatt, Operations Director at FCS, considers the effect of cloud on modern backup.

Can Government benefit from innovation and digital transformation proven in the Private Sector?

Chris Haden, CEO of Engeneum Limited, tells us about Private Sector Innovation that could equally provide public sector with improved efficiency, greater accuracy, and cost savings.

Fish oil microencapsulation: Improving human health with fortified food

Professor Charlotte Jacobsen and co-authors; Research Manager Heidi Johnsen, Dr. Rasa Slizyte, Dr. Revilija Mozuraityte, Dr. Wilhelm Glomm, Dr. Peter Molesworth, and Dr. Betül Yesiltas , explore how fish oil microencapsulation would allow for better fortification of food products and improve human health.

Climate change: From deep scientific understanding to practical solutions

Markku Kulmala, from the Institute for Atmospheric and Earth System Research, discusses the ACCC Flagship concerning adaptation to climate change, from deep scientific understanding to practical solutions.

Huntington’s Disease: Insight into disease mechanisms

Dr James E. Goldman, Professor of Pathology and Cell Biology at Columbia University, describes gaining more insight into disease mechanisms by comparing mouse genetic models with the human disease when it comes to Huntington’s Disease.

Key issues in the British legal aid system

Jonathan Wheeler, Solicitor and Managing Partner of London law firm Bolt Burdon Kemp, considers the key issues in today’s British legal aid system.

Why the public sector should embrace a hybrid cloud strategy

Jon Lucas, C-director of Hyve Managed Hosting, explains why the number of organisations in the public sector adopting a hybrid cloud strategy is growing, analyses what this shift means to these organisations.

Changing the treatment paradigm in Inflammatory Bowel Diseases

Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders